BCL2 and anemia: The markers were evaluated in the conjunction with different possible prognostic parameters including age, gender, bulky disease, the presence of B symptoms, anemia, LDH level, performance status, extranodal involvement, bone marrow and CNS involvement, staging IPI scoring, and associated Ki67 and BCL2 expression.